Psychodynamic psychopharmacology :: caring for the treatment-resistant patient /
"The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electroni...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, DC :
American Psychiatric Association Publishing,
[2022]
|
Ausgabe: | First edition. |
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | "The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"-- |
Beschreibung: | 1 online resource : illustrations |
Bibliographie: | Includes bibliographical references and index. |
ISBN: | 9781615374007 1615374000 1615371524 9781615371525 |
Internformat
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-on1288423458 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 211014s2022 dcua ob 001 0 eng | ||
010 | |a 2021050420 | ||
040 | |a DLC |b eng |e rda |c DLC |d OCLCO |d YDX |d EBLCP |d OCLCO |d YDX |d OCLCO |d OCLCF |d N$T |d OCLCQ |d OCLCO |d OCLCL | ||
019 | |a 1288149649 |a 1299383559 |a 1312328642 | ||
020 | |a 9781615374007 |q electronic book | ||
020 | |a 1615374000 |q electronic book | ||
020 | |z 9781615371525 |q paperback | ||
020 | |a 1615371524 |q (electronic bk.) | ||
020 | |a 9781615371525 |q (electronic bk.) | ||
035 | |a (OCoLC)1288423458 |z (OCoLC)1288149649 |z (OCoLC)1299383559 |z (OCoLC)1312328642 | ||
042 | |a pcc | ||
050 | 0 | 0 | |a RM315 |b .M5689 2022 |
060 | 0 | 0 | |a WM 402 |
082 | 7 | |a 615.7/88 |2 23/eng/20211209 | |
049 | |a MAIN | ||
100 | 1 | |a Mintz, David L., |e author. |0 http://id.loc.gov/authorities/names/nb2012018818 | |
245 | 1 | 0 | |a Psychodynamic psychopharmacology : |b caring for the treatment-resistant patient / |c by David Mintz. |
250 | |a First edition. | ||
264 | 1 | |a Washington, DC : |b American Psychiatric Association Publishing, |c [2022] | |
300 | |a 1 online resource : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care. | |
520 | |a "The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"-- |c Provided by publisher. | ||
588 | |a Description based on online resource; title from digital title page (viewed on March 31, 2022). | ||
650 | 0 | |a Psychopharmacology. |0 http://id.loc.gov/authorities/subjects/sh85108498 | |
650 | 0 | |a Psychotropic drugs. |0 http://id.loc.gov/authorities/subjects/sh85108528 | |
650 | 0 | |a Physician and patient. |0 http://id.loc.gov/authorities/subjects/sh85101608 | |
650 | 1 | 2 | |a Mental Disorders |x drug therapy |0 https://id.nlm.nih.gov/mesh/D001523Q000188 |
650 | 2 | 2 | |a Psychotropic Drugs |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D011619Q000627 |
650 | 2 | 2 | |a Treatment Refusal |x psychology |0 https://id.nlm.nih.gov/mesh/D016312Q000523 |
650 | 2 | 2 | |a Physician-Patient Relations |0 https://id.nlm.nih.gov/mesh/D010817 |
650 | 2 | |a Psychopharmacology |0 https://id.nlm.nih.gov/mesh/D011600 | |
650 | 2 | |a Psychotropic Drugs |0 https://id.nlm.nih.gov/mesh/D011619 | |
650 | 6 | |a Relations médecin-patient. | |
650 | 6 | |a Psychopharmacologie. | |
650 | 6 | |a Psychotropes. | |
650 | 7 | |a Physician and patient |2 fast | |
650 | 7 | |a Psychopharmacology |2 fast | |
650 | 7 | |a Psychotropic drugs |2 fast | |
710 | 2 | |a American Psychiatric Association Publishing, |e issuing body. |0 http://id.loc.gov/authorities/names/n2016180107 | |
758 | |i has work: |a Psychodynamic psychopharmacology (Text) |1 https://id.oclc.org/worldcat/entity/E39PCY3v9f9HBKrKDChvxm8hRC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |a Mintz, David L. |t Psychodynamic psychopharmacology |b First edition. |d Washington, DC : American Psychiatric Association Publishing, [2022] |z 9781615371525 |w (DLC) 2021050419 |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3182888 |3 Volltext |
938 | |a YBP Library Services |b YANK |n 302738619 | ||
938 | |a ProQuest Ebook Central |b EBLB |n EBL6893615 | ||
938 | |a EBSCOhost |b EBSC |n 3182888 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-on1288423458 |
---|---|
_version_ | 1816882554077184000 |
adam_text | |
any_adam_object | |
author | Mintz, David L. |
author_GND | http://id.loc.gov/authorities/names/nb2012018818 |
author_facet | Mintz, David L. |
author_role | aut |
author_sort | Mintz, David L. |
author_variant | d l m dl dlm |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RM315 |
callnumber-raw | RM315 .M5689 2022 |
callnumber-search | RM315 .M5689 2022 |
callnumber-sort | RM 3315 M5689 42022 |
callnumber-subject | RM - Therapeutics and Pharmacology |
collection | ZDB-4-EBA |
contents | What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care. |
ctrlnum | (OCoLC)1288423458 |
dewey-full | 615.7/88 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7/88 |
dewey-search | 615.7/88 |
dewey-sort | 3615.7 288 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | First edition. |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06657cam a2200685 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1288423458</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">211014s2022 dcua ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2021050420</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">DLC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDX</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDX</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1288149649</subfield><subfield code="a">1299383559</subfield><subfield code="a">1312328642</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781615374007</subfield><subfield code="q">electronic book</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1615374000</subfield><subfield code="q">electronic book</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781615371525</subfield><subfield code="q">paperback</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1615371524</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781615371525</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1288423458</subfield><subfield code="z">(OCoLC)1288149649</subfield><subfield code="z">(OCoLC)1299383559</subfield><subfield code="z">(OCoLC)1312328642</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">RM315</subfield><subfield code="b">.M5689 2022</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">WM 402</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.7/88</subfield><subfield code="2">23/eng/20211209</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mintz, David L.,</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/nb2012018818</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Psychodynamic psychopharmacology :</subfield><subfield code="b">caring for the treatment-resistant patient /</subfield><subfield code="c">by David Mintz.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC :</subfield><subfield code="b">American Psychiatric Association Publishing,</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"--</subfield><subfield code="c">Provided by publisher.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from digital title page (viewed on March 31, 2022).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Psychopharmacology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85108498</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Psychotropic drugs.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85108528</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Physician and patient.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85101608</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D001523Q000188</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Psychotropic Drugs</subfield><subfield code="x">therapeutic use</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D011619Q000627</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Treatment Refusal</subfield><subfield code="x">psychology</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016312Q000523</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Physician-Patient Relations</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D010817</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Psychopharmacology</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D011600</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Psychotropic Drugs</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D011619</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Relations médecin-patient.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Psychopharmacologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Psychotropes.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Physician and patient</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychopharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">American Psychiatric Association Publishing,</subfield><subfield code="e">issuing body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2016180107</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Psychodynamic psychopharmacology (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCY3v9f9HBKrKDChvxm8hRC</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Mintz, David L.</subfield><subfield code="t">Psychodynamic psychopharmacology</subfield><subfield code="b">First edition.</subfield><subfield code="d">Washington, DC : American Psychiatric Association Publishing, [2022]</subfield><subfield code="z">9781615371525</subfield><subfield code="w">(DLC) 2021050419</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3182888</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">302738619</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6893615</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3182888</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-on1288423458 |
illustrated | Illustrated |
indexdate | 2024-11-27T13:30:27Z |
institution | BVB |
institution_GND | http://id.loc.gov/authorities/names/n2016180107 |
isbn | 9781615374007 1615374000 1615371524 9781615371525 |
language | English |
lccn | 2021050420 |
oclc_num | 1288423458 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource : illustrations |
psigel | ZDB-4-EBA |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | American Psychiatric Association Publishing, |
record_format | marc |
spelling | Mintz, David L., author. http://id.loc.gov/authorities/names/nb2012018818 Psychodynamic psychopharmacology : caring for the treatment-resistant patient / by David Mintz. First edition. Washington, DC : American Psychiatric Association Publishing, [2022] 1 online resource : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care. "The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"-- Provided by publisher. Description based on online resource; title from digital title page (viewed on March 31, 2022). Psychopharmacology. http://id.loc.gov/authorities/subjects/sh85108498 Psychotropic drugs. http://id.loc.gov/authorities/subjects/sh85108528 Physician and patient. http://id.loc.gov/authorities/subjects/sh85101608 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Psychotropic Drugs therapeutic use https://id.nlm.nih.gov/mesh/D011619Q000627 Treatment Refusal psychology https://id.nlm.nih.gov/mesh/D016312Q000523 Physician-Patient Relations https://id.nlm.nih.gov/mesh/D010817 Psychopharmacology https://id.nlm.nih.gov/mesh/D011600 Psychotropic Drugs https://id.nlm.nih.gov/mesh/D011619 Relations médecin-patient. Psychopharmacologie. Psychotropes. Physician and patient fast Psychopharmacology fast Psychotropic drugs fast American Psychiatric Association Publishing, issuing body. http://id.loc.gov/authorities/names/n2016180107 has work: Psychodynamic psychopharmacology (Text) https://id.oclc.org/worldcat/entity/E39PCY3v9f9HBKrKDChvxm8hRC https://id.oclc.org/worldcat/ontology/hasWork Print version: Mintz, David L. Psychodynamic psychopharmacology First edition. Washington, DC : American Psychiatric Association Publishing, [2022] 9781615371525 (DLC) 2021050419 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3182888 Volltext |
spellingShingle | Mintz, David L. Psychodynamic psychopharmacology : caring for the treatment-resistant patient / What Is Psychodynamic Psychopharmacology? -- Why Psychodynamic Psychopharmacology? -- What Is Psychodynamic About Psychodynamic Psychopharmacology? -- Psychodynamics of Pharmacological Treatment Resistance -- Treatment Resistance to Medications -- Treatment Resistance From Medications -- The Prescriber's Contribution to Treatment Resistance -- Avoid a Mind-Body Split -- Know Who the Patient Is -- Attend to Patients' Ambivalence -- Cultivate the Pharmacotherapeutic Alliance -- Attend to Countertherapeutic Uses of Medications -- Identify, Contain, and Use Countertransference -- Who Is Psychodynamic Psychopharmacology For? Patient Characteristics -- Before Initiating Treatment -- The Engagement Phase -- The Maintenance Phase -- Split and Combined Treatments -- Psychodynamic Psychopharmacology and Integrated Care. Psychopharmacology. http://id.loc.gov/authorities/subjects/sh85108498 Psychotropic drugs. http://id.loc.gov/authorities/subjects/sh85108528 Physician and patient. http://id.loc.gov/authorities/subjects/sh85101608 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Psychotropic Drugs therapeutic use https://id.nlm.nih.gov/mesh/D011619Q000627 Treatment Refusal psychology https://id.nlm.nih.gov/mesh/D016312Q000523 Physician-Patient Relations https://id.nlm.nih.gov/mesh/D010817 Psychopharmacology https://id.nlm.nih.gov/mesh/D011600 Psychotropic Drugs https://id.nlm.nih.gov/mesh/D011619 Relations médecin-patient. Psychopharmacologie. Psychotropes. Physician and patient fast Psychopharmacology fast Psychotropic drugs fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85108498 http://id.loc.gov/authorities/subjects/sh85108528 http://id.loc.gov/authorities/subjects/sh85101608 https://id.nlm.nih.gov/mesh/D001523Q000188 https://id.nlm.nih.gov/mesh/D011619Q000627 https://id.nlm.nih.gov/mesh/D016312Q000523 https://id.nlm.nih.gov/mesh/D010817 https://id.nlm.nih.gov/mesh/D011600 https://id.nlm.nih.gov/mesh/D011619 |
title | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / |
title_auth | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / |
title_exact_search | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / |
title_full | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / by David Mintz. |
title_fullStr | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / by David Mintz. |
title_full_unstemmed | Psychodynamic psychopharmacology : caring for the treatment-resistant patient / by David Mintz. |
title_short | Psychodynamic psychopharmacology : |
title_sort | psychodynamic psychopharmacology caring for the treatment resistant patient |
title_sub | caring for the treatment-resistant patient / |
topic | Psychopharmacology. http://id.loc.gov/authorities/subjects/sh85108498 Psychotropic drugs. http://id.loc.gov/authorities/subjects/sh85108528 Physician and patient. http://id.loc.gov/authorities/subjects/sh85101608 Mental Disorders drug therapy https://id.nlm.nih.gov/mesh/D001523Q000188 Psychotropic Drugs therapeutic use https://id.nlm.nih.gov/mesh/D011619Q000627 Treatment Refusal psychology https://id.nlm.nih.gov/mesh/D016312Q000523 Physician-Patient Relations https://id.nlm.nih.gov/mesh/D010817 Psychopharmacology https://id.nlm.nih.gov/mesh/D011600 Psychotropic Drugs https://id.nlm.nih.gov/mesh/D011619 Relations médecin-patient. Psychopharmacologie. Psychotropes. Physician and patient fast Psychopharmacology fast Psychotropic drugs fast |
topic_facet | Psychopharmacology. Psychotropic drugs. Physician and patient. Mental Disorders drug therapy Psychotropic Drugs therapeutic use Treatment Refusal psychology Physician-Patient Relations Psychopharmacology Psychotropic Drugs Relations médecin-patient. Psychopharmacologie. Psychotropes. Physician and patient Psychotropic drugs |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3182888 |
work_keys_str_mv | AT mintzdavidl psychodynamicpsychopharmacologycaringforthetreatmentresistantpatient AT americanpsychiatricassociationpublishing psychodynamicpsychopharmacologycaringforthetreatmentresistantpatient |